Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000055

EVP, Chief Business Officer sold 4,430 shares at $32.70 ($144,861)

  • EVP, Chief Business Officer acquired 11,247 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Baroldi Joseph · EVP, Chief Business Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-15 Exercise or conversion : show line 1 in the form +8,787 28,418 D
2025-01-16 Sale : show line 2 in the form −3,401 $32.70 $111,213 25,017 D
2025-01-15 Exercise or conversion : show line 3 in the form +2,460 4,100 I
2025-01-16 Sale : show line 4 in the form −1,029 $32.70 $33,648 3,071 I
Open-market sales · 4,430 sh · avg $32.70 · $144,861

Table II: Derivative

5 lines
Date Transaction Shares Exercise Underlying Owned after D/I
2025-01-15 Grant or award : show line 5 in the form Performance Restricted Stock Units +22,000 $0.00 22,000 51,290 D
2025-01-15 Grant or award : show line 6 in the form Restricted Stock Unit +33,000 $0.00 33,000 86,135 D
2025-01-15 Exercise or conversion : show line 7 in the form Restricted Stock Unit −8,787 $0.00 8,787 77,348 D
2025-01-15 Grant or award : show line 8 in the form Restricted Stock Unit +3,750 $0.00 3,750 10,784 I
2025-01-15 Exercise or conversion : show line 9 in the form Restricted Stock Unit −2,460 $0.00 2,460 8,324 I
Loading xslF345X05/edgardoc.xml…